Searched over 200M research papers
10 papers analyzed
Some studies suggest beta blockers may cause fatigue and tiredness, while other studies indicate only small increased risks or no significant association with fatigue.
9 papers analyzed
20 papers analyzed
Beta blockers, first reported for their hypotensive effects in 1964, are widely used to treat various cardiovascular conditions such as hypertension, angina pectoris, and cardiac arrhythmias. They are also prescribed for non-cardiovascular conditions like essential tremor and migraine. Despite their benefits, beta blockers are associated with several side effects, including fatigue.
A significant number of patients on beta blockers report experiencing general fatigue. This fatigue can manifest as a persistent sense of tiredness and malaise throughout the day, affecting both physical and mental states. Studies have shown that the incidence of fatigue varies among different beta blockers, with propranolol and atenolol being commonly associated with this side effect.
Beta blockers can also affect the central nervous system (CNS), leading to symptoms such as drowsiness and sleep disturbances. Lipophilic beta blockers, which can cross the blood-brain barrier more easily, are particularly noted for causing increased wakefulness and restlessness during sleep. For instance, propranolol and metoprolol have been reported to increase the number of awakenings and time spent awake during the night.
A meta-analysis of randomized clinical trials involving over 35,000 subjects found that beta blockers are associated with a small but significant increase in the risk of reported fatigue. This translates to approximately one additional report of fatigue for every 57 patients treated per year. The risk of fatigue was found to be higher for early-generation beta blockers compared to later-generation ones.
Studies using visual analogue scales (VAS) have consistently shown that patients on beta blockers report higher incidences of tired legs and overall tiredness compared to those not on these medications . These scales have proven to be sensitive tools for measuring the prevalence of such side effects among hypertensive patients.
The mechanisms contributing to muscle fatigue in patients taking beta blockers include the inhibition of Na(+)-K+ ATPase pumps, which control ion movement between muscle and plasma. This inhibition can lead to increased plasma potassium levels during exercise, thereby impairing exercise performance and contributing to muscle fatigue.
In summary, beta blockers are associated with various forms of fatigue, including general tiredness, muscle fatigue, and CNS-related symptoms like drowsiness and sleep disturbances. While the incidence of these side effects can vary depending on the specific beta blocker and its properties, the overall increase in fatigue is relatively small but significant. Patients and clinicians should weigh these risks against the substantial benefits of beta blocker therapy in managing cardiovascular and other conditions.
Most relevant research papers on this topic